tai Cactus Biotech Inc. is market-leading cactus grower and
producer of cactus-related products with over 387 acres of plants and an
active R&D group that holds 15 product patents and is seeking another 15 in
a variety of product categories. China Kangtai's high-quality products are
sold throughout China in supermarkets, food stores, hotels and restaurants
through a growing distribution network that has currently covered 14
provinces and 4 municipalities.
About T Squared Investments LLC
T Squared Partners and T Squared Investments LLC is a fundamentally-
oriented private investment firm focusing on special situation and value
growth oriented micro-cap public and private companies. The fund's
philosophy is to work with companies to enhance their shareholder value
through friendly investment structures in addition to providing industry
leading strategic advice.
Cautionary Statement Regarding Forward-looking Information
This press release contains forward-looking information about China
Kangtai Cactus Biotech that is intended to be covered by the safe harbor
for forward-looking statements provided by the Private Securities
Litigation Reform Act of 1995. Forward-looking statements are statements
that are not historical facts. These statements can be identified by the
use of forward- looking terminology such as "believe," "expect," "may,"
"will," "should," "project," "plan," "seek," "intend," or "anticipate" or
the negative thereof or comparable terminology, and include discussions of
strategy, and statements about industry trends and China Kangtai Cactus
Biotech future performance, operations and products.
For more information, please contact:
China Kangtai Cactus Biotech, Inc.
Page: 1 2 Related biology technology :1
|SOURCE China Kangtai Cactus Bio-Tech, Inc.|
Copyright©2008 PR Newswire.
All rights reserved
. Aida Pharmaceuticals, Inc. Acquires High-Level Research Institute in the Peoples Republic of China2
. Aida Acquires High-Level Research Institute in China3
. China Pharma Holdings, Inc. Announces Earnings Call for Fiscal 2007 Financial Results4
. China Biopharma Reaches Agreement with a Regional Pharma to Launch New Pharmaceutical Products5
. China Biologic Products Announces One of Its R&D Projects Has Been Listed In National Torch Plan6
. Lucids VivaScope(R) Reflective Confocal Microscope Approved for Sale in China7
. China Aoxing Pharmaceutical Company Signed Definitive Acquisition Agreement to Acquire Shijiazhuang Lerentang Pharmaceutical Company, Ltd.8
. Pharmaxis First Steps into China9
. Hovione Buys Drug Manufacturing Facility in China10
. China Nepstar Chain Drugstore to Acquire 18 Stores from Dongguan Hui Ren Tang Pharmaceutical Co.11
. China Yingxia International Announces Q4 and FY 2007 Estimates